TPO-RA Plus Baricitinib vs. TPO-RA for ITP

NCT07669675 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

ITP - Immune Thrombocytopenia

Interventions

DRUG: Baricitinib
DRUG: TPO-RA

Sponsor

Peking University People's Hospital